Sign Up to like & get
recommendations!
0
Published in 2018 at "Advances in biological regulation"
DOI: 10.1016/j.jbior.2017.11.007
Abstract: Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most chemoresistant cancers, and current therapies targeting cancer-associated molecular pathways have not given satisfactory results, owing in part to rapid upregulation of alternative compensatory pathways. Most of…
read more here.
Keywords:
molecular cellular;
cellular mechanisms;
pancreatic cancer;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.19048
Abstract: Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer patients because chemoresistance causes recurrence, cancer dissemination and death. This review summarizes numerous molecular aspects of multi-resistance, including transporter pumps, oncogenes (EGFR,…
read more here.
Keywords:
chemoresistance;
emt;
chemoresistance cancers;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Translational cancer research"
DOI: 10.21037/tcr.2017.12.20
Abstract: Colon cancer is the second leading cause of cancer death among both men and women in the United States. Even with available chemotherapies, a significant number of patients have recurrent disease, leading to the high…
read more here.
Keywords:
chemoresistance fusobacterium;
novel mechanisms;
fusobacterium nucleatum;
cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14194966
Abstract: Simple Summary Despite advances in chemotherapy for retinoblastoma over the past three decades, chemoresistance remains a major source of ocular and systemic morbidity. Here, we studied the early molecular mechanisms leading to carboplatin resistance. Carboplatin…
read more here.
Keywords:
retinoblastoma;
early mechanisms;
mechanisms leading;
chemoresistance ... See more keywords